Compare · DHR vs MASS
DHR vs MASS
Side-by-side comparison of Danaher Corporation (DHR) and 908 Devices Inc. (MASS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DHR and MASS operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- DHR is the larger of the two at $130.44B, about 435.0x MASS ($299.9M).
- DHR has been more active in the news (16 items in the past 4 weeks vs 10 for MASS).
- DHR has more recent analyst coverage (25 ratings vs 5 for MASS).
- Company
- Danaher Corporation
- 908 Devices Inc.
- Price
- -
- -
- Market cap
- $130.44B
- $299.9M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 16
- 10
- Recent ratings
- 25
- 5
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
908 Devices Inc.
908 Devices Inc. develops and sells measurement devices for chemical and biochemical analysis in North America, Europe, the Middle East, Africa, and the Asia Pacific. It offers handheld and desktop mass spectrometry (Mass Spec) devices for the point-of-need applications in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Latest DHR
- Danaher Corporation filed SEC Form 8-K: Other Events
- DZ Bank initiated coverage on Danaher with a new price target
- Wolfe Research resumed coverage on Danaher
- SCIEX Launches the novus V55 System With SCIEX OS 5.0 Software and AI Enablement Tools
- SCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key Collaborations
- Citigroup resumed coverage on Danaher with a new price target
- Henry Schein Announces the Election of William K. "Dan" Daniel as Independent Chairman of the Board
- SVP, Human Resources Couchara Georgeann covered exercise/tax liability with 281 shares, decreasing direct ownership by 3% to 8,291 units (SEC Form 4)
- Director Filler Linda was granted 680 shares, increasing direct ownership by 3% to 24,712 units (SEC Form 4)
- Director Stevens Raymond C was granted 680 shares, increasing direct ownership by 5% to 13,728 units (SEC Form 4)
Latest MASS
- Director Brown Christopher D. sold $900 worth of shares (100 units at $9.00) as part of a pre-agreed trading plan, decreasing direct ownership by 0.01% to 875,459 units (SEC Form 4)
- Large owner Awm Investment Company, Inc. sold $379,231 worth of 908 DEVICES (42,282 units at $8.97) (SEC Form 4)
- Director Brown Christopher D. sold $174,600 worth of shares (20,000 units at $8.73) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 875,559 units (SEC Form 4)
- 908 Devices Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Large owner Awm Investment Company, Inc. sold $1,612,091 worth of 908 DEVICES (186,942 units at $8.62) (SEC Form 4)
- Director Brown Christopher D. sold $270,000 worth of shares (30,000 units at $9.00) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 895,559 units (SEC Form 4)
- Chief Financial Officer Griffith Joseph H. Iv sold $62,668 worth of shares (6,940 units at $9.03) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 132,956 units (SEC Form 4)
- SEC Form 144 filed by 908 Devices Inc.
- SEC Form SD filed by 908 Devices Inc.
- 908 Devices to Present at the 16th Annual East Coast IDEAS Investor Conference